March 10, 2020
The Medicare Payment Advisory Commission (MedPAC) met on March 5-6 to consider presentations and recommendations from MedPAC staff related to quality improvement, risk adjustment and payment innovation.
Addressing Medicare Shared Savings Program Vulnerabilities
The Commission continued discussions surrounding how to best align base year estimates with performance year spending for accountable care organizations (ACOs) participating in the Medicare Shared Savings Program. The Commission will vote on the recommendation supporting the use of national provider identifiers to compute both performance and baseline spending. Presentation slides are available here.
The role of specialists in alternative payment models and accountable care organizations
In response to previous discussions, MedPAC staff presented on the current role and participation of specialists in ACOs. Staff determined, that while specialists constitute a majority of providers enrolled in ACOs (63%), they have a limited role and impact on these models. The Commission provided feedback and will consider additional data during a future public meeting. Presentation slides are available here.
Redesigning the Medicare Advantage quality bonus program
MedPAC staff presented a draft recommendation to replace the current Medicare Advantage (MA) quality bonus program (QBP) and replace it with the MA value incentive program (VIP). The Commission was in general agreement, and will vote on the recommendation during the April public meeting. Presentation slides are available here.
The impact of changes in the 21st Century Cures Act to risk adjustment for Medicare Advantage enrollees
As part of a mandated report, MedPAC staff presented evaluation results of the changes made to risk adjustment for MA enrollees. The Commission agreed with the direction of the report and it will be included in a chapter of the June Report to Congress. Presentation slides are available here.
MedPAC is next scheduled to meet April 2-3, 2020
MedPAC is an independent congressional agency established by the Balanced Budget Act of 1997 (P.L. 105-33) to advise the US Congress on issues affecting the Medicare program.